TABLE 1.
Laboratory identification | State | Year | Pt age (yr) | Site of isolation | Serotype | MIC (μg/ml)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
AMP | PEN | CTX | CFX | CFZ | CFR | ||||||
3047-05 | MN | 2004 | 49 | Blood | IA | 0.12 | 0.06 | 0.06 | 8 | 0.25 | 0.06 |
5662-05 | MN | 2004 | 0 | Blood | IA | 0.12 | 0.06 | 0.06 | 8 | 0.25 | 0.03 |
6649-05 | CO | 2005 | 58 | Blood | IA | 0.25 | 0.12 | 0.12 | 4 | 0.5 | ND |
7490-03 | MD | 2003 | 64 | Blood | IA | 0.12 | 0.06 | 0.12 | 2 | 0.25 | 0.06 |
9012-04 | GA | 2004 | 48 | PTL fluid | IA | 0.06 | 0.06 | 0.06 | 16 | 0.25 | 0.06 |
5436-03 | OR | 2001 | 53 | Blood | IB | 0.06 | 0.03 | 0.25 | 16 | 1 | 0.25 |
3776-04 | MN | 2003 | 71 | Joint | II | 0.25 | 0.12 | 0.12 | 8 | 0.25 | 0.12 |
9051-04 | MN | 2004 | 90 | Blood | II | 0.12 | 0.06 | 0.06 | 8 | 0.25 | 0.06 |
3444-99 | GA | 1999 | 0 | Blood | III | 0.12 | 0.06 | 0.06 | 8 | 0.25 | 0.06 |
7037-99 | GA | 1999 | 0 | Blood | III | 0.12 | 0.06 | 0.12 | 8 | 0.25 | 0.06 |
3789-04 | MN | 2003 | 78 | Blood | III | 0.12 | 0.12 | 0.25 | 16 | 1 | 0.12 |
6138-03 | NY | 2003 | 90 | Blood | III | 0.06 | 0.12 | 0.25 | 16 | 0.5 | 0.25 |
7507-03 | MD | 2003 | 82 | Blood | III | 0.12 | 0.12 | 0.12 | 16 | 0.5 | 0.12 |
8607-03 | NY | 2003 | 81 | Blood | III | 0.06 | 0.12 | 0.25 | 16 | 0.5 | 0.12 |
3454-03 | MN | 2002 | 73 | PTL fluid | IV | 0.25 | 0.12 | 0.25 | 8 | 0.5 | 0.06 |
4214-03 | NY | 2002 | 32 | Bone | NT | 0.25 | 0.12 | 0.12 | 4 | 0.5 | 0.12 |
6149-03 | NY | 2003 | 76 | Blood | NT | 0.12 | 0.06 | 0.06 | 8 | 0.25 | 0.06 |
7368-04 | MD | 2004 | 45 | Blood | NT | 0.12 | 0.12 | 0.06 | 4 | 0.5 | 0.06 |
3386-05 | MD | 2004 | 69 | Blood | V | 0.06 | 0.03 | 0.06 | 16 | 0.12 | ND |
4857-03 | NY | 2002 | 84 | Joint | V | 0.25 | 0.12 | 0.06 | 4 | 0.5 | 0.06 |
5677-04 | MD | 2003 | 74 | Joint | V | 0.25 | 0.12 | 0.12 | 16 | 1 | 0.12 |
9171-03 | GA | 2003 | 49 | Blood | V | 0.12 | 0.06 | 0.12 | 4 | 0.25 | 0.06 |
PTL, preterm labor fluid; AMP, ampicillin; PEN, penicillin; CTX, cefotaxime; CFX, cefoxitin; CFZ, cefazolin; CFR, cefuroxime. MICs that are considered unusually high are underlined. The four isolates that shared the Q557E pbp2x mutation and multilocus sequence type ST19 are in bold.